Asciminib Treatment Optimization in ≥ 3rd Line CML-CP
Novartis
Novartis
Takeda
Institut Paoli-Calmettes
Massachusetts General Hospital
Roswell Park Cancer Institute
Gamida Cell ltd
M.D. Anderson Cancer Center
National Heart, Lung, and Blood Institute (NHLBI)
Dana-Farber Cancer Institute
University of Rochester
Massachusetts General Hospital
M.D. Anderson Cancer Center
Brown University
Ohio State University Comprehensive Cancer Center
Novartis
Center for International Blood and Marrow Transplant Research
Centre Henri Becquerel
M.D. Anderson Cancer Center
Masonic Cancer Center, University of Minnesota
M.D. Anderson Cancer Center